Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CIMETIDINE HYDROCHLORIDE

CIMETIDINE HYDROCHLORIDE

Standard Dose
EQ 300MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CIMETIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 075560 (ANDA).

Marketing status: Discontinued Active ingredient CIMETIDINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 300MG BASE/5ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2001-01-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview CIMETIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 075560 (ANDA). Marketing status: Discontinued Active ingredient CIMETIDINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 300MG BASE/5ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2001-01-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: UNKNOWN
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
CIMETIDINE HYDROCHLORIDE (CIMETIDINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline